HEALTHY PARTICIPANT
Clinical trials for HEALTHY PARTICIPANT explained in plain language.
Never miss a new study
Get alerted when new HEALTHY PARTICIPANT trials appear
Sign up with your email to follow new studies for HEALTHY PARTICIPANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pfizer tests heart drug safety in healthy volunteers
Knowledge-focused CompletedThis study looked at how a new medicine, PF-07328948, is handled by the body and whether it is safe in healthy Chinese adults. Ten participants took the drug daily for a week. The goal was to gather early safety and drug-level information to support future heart failure treatment…
Matched conditions: HEALTHY PARTICIPANT
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Pfizer checks if new atirmociclib tablet matches the old one
Knowledge-focused CompletedThis completed Phase 1 study tested whether a new, higher-dose tablet of the cancer drug atirmociclib works the same in the body as the current tablet. Thirty-five healthy adults each received a single dose of both tablet forms after a meal, in random order. The goal was to see i…
Matched conditions: HEALTHY PARTICIPANT
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Ibuzatrelvir drug study in healthy chinese volunteers completed
Knowledge-focused CompletedThis early-stage study looked at how the drug Ibuzatrelvir (PF-07817883) is absorbed and processed in the body of 12 healthy Chinese adults after a single dose. The goal was to measure drug levels in the blood and check for any side effects. Since participants were healthy, this …
Matched conditions: HEALTHY PARTICIPANT
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:09 UTC